āļ§ัāļ™āļˆัāļ™āļ—āļĢ์āļ—ี่ 6 āđ€āļĄāļĐāļēāļĒāļ™ āļž.āļĻ. 2569

Snoring (Primary snoring / habitual snoring)

Snoring (Primary snoring / habitual snoring)


🔑 Definition & Epidemiology

  • āđ€āļŠีāļĒāļ‡āļˆāļēāļ vibration āļ‚āļ­āļ‡ upper airway soft tissue āļĢāļ°āļŦāļ§่āļēāļ‡ sleep
  • āļžāļšāđ„āļ”้āļš่āļ­āļĒāļĄāļēāļ
    • āļŠāļēāļĒ ~44%
    • āļŦāļิāļ‡ ~28% (āļ­āļēāļĒุ 30–60 āļ›ี)
  • Occasional snoring āļžāļšāđ„āļ”้āđāļ—āļšāļ—ุāļāļ„āļ™

🧠 Pathophysiology (Key clinical concept)

  • āļāļĨāđ„āļāļŦāļĨัāļ:
    • upper airway resistance
    • pharyngeal collapsibility
  • āļˆุāļ”āļŠāļģāļ„ัāļ:
    • Anterior nasal valve = narrowest segment highest resistance
  • Progression:

1.                   mild snoring only

2.                   moderate RERA (respiratory effort related arousal)

3.                   severe OSA (apnea/hypopnea + desaturation)


⚠️ Associated conditions (āļ•้āļ­āļ‡āļ„ิāļ”āđ€āļŠāļĄāļ­)

1. Obstructive Sleep Apnea (OSA)

  • Snoring = marker āļ‚āļ­āļ‡ OSA
  • Habitual snorer:
    • āļŠāļēāļĒ ~34%
    • āļŦāļิāļ‡ ~19% āļĄี OSA

2. Upper airway narrowing causes

  • Obesity
  • Nasal obstruction (allergic rhinitis, septal deviation)
  • Craniofacial abnormality
  • Adenotonsillar hypertrophy
  • Hypothyroidism / acromegaly

📈 Natural history

  • Weight gain progression to OSA (strongest factor)
  • BMI 1 unit AHI ~5 events/hr

❤️ Clinical consequences

Strong evidence

  • 🧠 Carotid atherosclerosis (dose-response relationship)

Weak / unclear

  • Hypertension likely confounded by OSA
  • Ischemic heart disease no clear independent association

Practical consequence

  • Bed partner sleep disturbance significant QoL impact

🔍 Evaluation (focus = rule out OSA)

1. History (include bed partner)

  • Loud habitual snoring
  • Witnessed apnea
  • Gasping/choking
  • Daytime sleepiness
  • Morning headache, poor concentration
  • Risk factors:
    • obesity
    • alcohol
    • smoking
    • sedatives (benzodiazepine)

2. Physical exam

  • Large neck circumference
  • Crowded oropharynx
  • Nasal obstruction / turbinate hypertrophy
  • Craniofacial abnormality
  • Signs endocrine disease (hypothyroid, acromegaly)

3. Screening tools

  • STOP-Bang
  • Berlin questionnaire

4. Indication for sleep study

  • Loud snoring + 1:
    • witnessed apnea
    • daytime sleepiness
    • obesity
    • CV disease

āļŠ่āļ‡ polysomnography / home sleep apnea test


ðŸ§ū Management

ðŸŸĒ 1. Conservative (first-line)

  • Weight loss (strongest evidence)
  • Avoid:
    • alcohol (especiallyāļ่āļ­āļ™āļ™āļ­āļ™)
    • smoking
  • Sleep position:
    • lateral position (positional therapy)
  • Optimize nasal patency:
    • saline irrigation
    • short-term decongestant
    • intranasal steroid (chronic rhinitis)

ðŸŸĄ 2. Devices

Oral appliance (mandibular advancement device)

  • First choice if conservative fail
  • Effect:
    • snoring intensity & frequency (good evidence)
  • Side effects:
    • jaw discomfort, salivation, occlusal change

Nasal dilator

  • Low risk trial āđ„āļ”้

CPAP

  • Effective āđāļ•่:
    • compliance āļ•่āļģāļ–้āļēāđ„āļĄ่āļĄี OSA

ðŸ”ī 3. Surgery (last option)

  • Indication: refractory cases
  • Options:
    • UPPP (uvulopalatopharyngoplasty)
    • LAUP (laser-assisted UPPP)
    • Radiofrequency ablation
    • Palatal implants

⚠️ Limitations:

  • Effect āļĨāļ”āļĨāļ‡āļĢāļ°āļĒāļ°āļĒāļēāļ§
  • āļ­āļēāļˆ mask OSA
  • complication: pain, dysphonia, reflux, bleeding

🧠 4. Myofunctional therapy

  • Oropharyngeal exercises
  • Evidence: moderate benefit (selected patients)

Not recommended

  • Lubricating nasal sprays ineffective

📌 Practical clinical approach (āđƒāļŠ้āļˆāļĢิāļ‡)

1.       Snoring screen OSA first

2.       āļ–้āļē OSA treat OSA

3.       āļ–้āļē primary snoring:

o   lifestyle + positional

o   nasal optimization

o   oral appliance

o   surgery (last)


ðŸ’Ą Key take-home for ER / OPD

  • Snoring benign āđ€āļŠāļĄāļ­ āļ•้āļ­āļ‡āļ„ิāļ”āļ–ึāļ‡ OSA
  • Weight gain = strongest modifiable risk
  • āļ–้āļēāļĄี daytime sleepiness + snoring āļŠ่āļ‡ sleep study
  • Treatment snoring alone mainly QoL indication (partner)

āđ„āļĄ่āļĄีāļ„āļ§āļēāļĄāļ„ิāļ”āđ€āļŦ็āļ™:

āđāļŠāļ”āļ‡āļ„āļ§āļēāļĄāļ„ิāļ”āđ€āļŦ็āļ™